Influence-Tools/republic-os
2
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity
Files
main
republic-os/legislation/us/states/ca/20212022/sb-1500.md
T
Fabio 5a13be122b Legislation: batch E — CA TN VA VT WA WI WV WY 
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
2026-07-06 17:28:36 -04:00

8.0 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Public health: federal regulation. The Sherman Food, Drug, and Cosmetic Law regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. The law prohibits the sale, delivery, or giving away of any new drug or new device unless either the department has approved a new drug or device application for that new drug or new device and that approval has not been withdrawn, terminated, or suspended under specified provisions of the federal Food, Drug, and Cosmetic Act, or it is a new device for which a premarket approval application has been approved, and that approval has not been withdrawn, terminated, or suspended under the federal act. Existing law exempts a drug or device intended solely for investigational use of a drug or device if the investigation is conducted in accordance with specified provisions of the federal act. us/states/ca California Legislature 20212022 SB 1500 California SB 1500 (20212022)
bill
Public health: federal regulation.
enacted
Committee on Health
6 34 9 2022-04-20 2022-09-30 openstates ocd-bill/bcf321b1-b990-465e-a33e-c535358556a7 http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202120220SB1500 ac2338ef7cb5bc5807799726d16adaa6a2ceab11b88bf3003cd3a9da6f2e4f99 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-ca

California SB 1500 (20212022) — Public health: federal regulation.

The Sherman Food, Drug, and Cosmetic Law regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. The law prohibits the sale, delivery, or giving away of any new drug or new device unless either the department has approved a new drug or device application for that new drug or new device and that approval has not been withdrawn, terminated, or suspended under specified provisions of the federal Food, Drug, and Cosmetic Act, or it is a new device for which a premarket approval application has been approved, and that approval has not been withdrawn, terminated, or suspended under the federal act. Existing law exempts a drug or device intended solely for investigational use of a drug or device if the investigation is conducted in accordance with specified provisions of the federal act.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. 04/20/22 - Introduced (filed) — source
  2. 06/13/22 - Amended Assembly (committee substitute) — source
  3. 08/25/22 - Amended Assembly (committee substitute) — source
  4. 09/30/22 - Chaptered (committee substitute) — source
  5. SB1500 (committee substitute) — source
  6. 09/08/22 - Enrolled (enrolled) — source

Votes

  • Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar — 10–0 (pass) · upper
  • Special Consent SB1500 HEALTH — 39–0 (pass) · upper
  • Unfinished Business SB1500 HEALTH (Pan) Concurrence — 40–0 (pass) · upper
  • Do pass — 7–0 (pass) · upper
  • SB 1500 HEALTH Consent Calendar Second Day — 76–0 (pass) · lower
  • Placed on suspense file — 7–0 (pass) · upper
  • Do pass. To Consent Calendar. — 15–0 (pass) · lower
  • Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar — 15–0 (pass) · lower
  • SB 1500 HEALTH Senate Third Reading By WOOD — 78–0 (pass) · lower

Sponsors

  • Committee on Health — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2022-04-20 Introduced. Read first time. To Com. on RLS. for assignment. To print. introduction, reading-1
  • 2022-04-20 Article IV Section 8(a) of the Constitution and Joint Rule 55 dispensed with February 7, 2022, suspending the 30 calendar day requirement.
  • 2022-04-21 From printer.
  • 2022-04-22 Set for hearing April 27 in HEALTH pending receipt.
  • 2022-04-25 Referred to Com. on HEALTH. referral-committee
  • 2022-04-28 From committee: Do pass and re-refer to Com. on APPR with recommendation: To consent calendar. (Ayes 10. Noes 0. Page 3543.) (April 27). Re-referred to Com. on APPR. committee-passage, committee-passage-favorable, referral-committee
  • 2022-04-29 Set for hearing May 9.
  • 2022-05-09 May 9 hearing: Placed on APPR suspense file.
  • 2022-05-13 Set for hearing May 19.
  • 2022-05-19 From committee: Do pass. (Ayes 7. Noes 0. Page 3798.) (May 19). committee-passage, committee-passage-favorable
  • 2022-05-19 Read second time. Ordered to third reading. reading-1, reading-2
  • 2022-05-23 Ordered to special consent calendar.
  • 2022-05-25 Read third time. Passed. (Ayes 39. Noes 0. Page 3938.) Ordered to the Assembly. passage, reading-1, reading-3
  • 2022-05-26 In Assembly. Read first time. Held at Desk. reading-1
  • 2022-06-02 Referred to Com. on HEALTH. referral-committee
  • 2022-06-13 From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH. amendment-passage, committee-passage, reading-1, reading-2, referral-committee
  • 2022-06-21 June 21 hearing postponed by committee.
  • 2022-06-29 From committee: Do pass and re-refer to Com. on APPR. with recommendation: To consent calendar. (Ayes 15. Noes 0.) (June 28). Re-referred to Com. on APPR. committee-passage, committee-passage-favorable, referral-committee
  • 2022-08-03 From committee: Do pass. Ordered to consent calendar. (Ayes 15. Noes 0.) (August 3). committee-passage, committee-passage-favorable
  • 2022-08-04 Read second time. Ordered to consent calendar. reading-1, reading-2
  • 2022-08-11 Read third time. Passed. (Ayes 76. Noes 0. Page 5830.) Ordered to the Senate. passage, reading-1, reading-3
  • 2022-08-11 In Senate. Concurrence in Assembly amendments pending.
  • 2022-08-24 Ordered to the Assembly.
  • 2022-08-24 In Assembly. Held at Desk.
  • 2022-08-24 Action rescinded whereby the bill was read a third time, passed, and ordered to the Senate.
  • 2022-08-24 Ordered to third reading.
  • 2022-08-25 Read third time and amended. amendment-passage, reading-1, reading-3
  • 2022-08-25 Ordered to third reading.
  • 2022-08-31 Read third time. Passed. Ordered to the Senate. passage, reading-1, reading-3
  • 2022-08-31 In Senate. Concurrence in Assembly amendments pending.
  • 2022-08-31 Assembly amendments concurred in. (Ayes 40. Noes 0. Page 5416.) Ordered to engrossing and enrolling. amendment-passage, committee-passage-favorable
  • 2022-09-13 Enrolled and presented to the Governor at 3 p.m.
  • 2022-09-30 Approved by the Governor. executive-signature
  • 2022-09-30 Chaptered by Secretary of State. Chapter 955, Statutes of 2022. became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/bcf321b1-b990-465e-a33e-c535358556a7. Confidence: reported (aggregated from official California legislature records).

Reference in New Issue View Git Blame Copy Permalink